Every year, more than 178 million people worldwide suffer from bone fracture injuries. The current methods of pain management, typically relying on nonsteroidal anti-inflammatory drugs (NSAIDs) like aspirin, have their limitations.
Researchers say that monoclonal antibodies have the potential as a monthly non-addictive pain medication that can replace opioids for people with chronic pain.
Whether it's a headache, a bruised muscle, or recovery from an injury, it's almost instinctual for many people to quickly turn to common painkillers for immediate relief.